seekingalpha.com · 2 jul

Prologis: The Moat Keeps Getting Wider

Prologis, Inc. maintains a robust competitive moat through prime locations, scale, and expansion into data centers and renewable energy services. PLD's embedded growth is underpinned by a 17% mark-to-market rent spread (~$750M in lease rollover revenue) and a $42B development pipeline. The REIT's strong balance sheet, 3.3% average interest rate, and nearly 8-year debt maturity enable opportunistic growth and M&A flexibility.

prnewswire.com · 1 jul

Prologis Appoints Alfred F. Kelly, Jr. to Board of Directors

SAN FRANCISCO, July 1, 2026 /PRNewswire/ -- Prologis, Inc. (NYSE: PLD) today announced that its board of directors appointed Alfred F. Kelly, Jr. as a director of the company.

zacks.com · 24 jun

Earnings Growth & Price Strength Make Prologis (PLD) a Stock to Watch

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.

proactiveinvestors.com · 24 jun

American Rare Earths strengthens board with veteran Wyoming mine builder ahead of planned Nasdaq listing

Veteran mine builder Matthew Gili will join American Rare Earths Ltd (ASX:ARR, OTCQX:ARRNF)'s board as a non-executive director as the company advances the...

fool.com · 24 jun

Breakfast News: Prologis Is Shopping For Growth

PLD has a takeover bid rejected, Walmart snaps up French ad-tech company, and more

proactiveinvestors.com · 24 jun

Prologis 'clearly' can make a higher offer to secure Segro deal, analysts say

Segro PLC's (LSE:SGRO) rejection of a £12.6 billion takeover approach from US giant Prologis Inc (NYSE:PLD) may be only the opening round in what could...

proactiveinvestors.co.uk · 24 jun

Prologis 'clearly' can make a higher offer to secure Segro deal, analysts say

Segro PLC's (LSE:SGRO) rejection of a £12.6 billion takeover approach from US giant Prologis Inc (NYSE:PLD) may be only the opening round in what could become one of the biggest UK property deals in years. The US logistics giant's all-share proposal valued Segro at 925p a share, a 24.6% premium to the undisturbed share price and broadly in line with the company's last reported net asset value.

proactiveinvestors.com · 24 jun

Coiled Therapeutics appoints biotech veteran Craig Tooman to board

Coiled Therapeutics (AIM:COIL, OTCQB:COTXF), the AIM-listed clinical-stage oncology company, has appointed Craig Tooman as an independent non-executive...